GTHX Annual FCF
-$38.34 M
+$90.79 M+70.31%
31 December 2023
Summary:
As of February 1, 2025, GTHX annual free cash flow is -$38.34 million, with the most recent change of +$90.79 million (+70.31%) on December 31, 2023. During the last 3 years, it has risen by +$45.41 million (+54.22%).GTHX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly FCF
-$5.27 M
+$3.62 M+40.73%
30 June 2024
Summary:
As of February 1, 2025, GTHX quarterly free cash flow is -$5.27 million, with the most recent change of +$3.62 million (+40.73%) on June 30, 2024. Over the past year, it has dropped by -$19.36 million (-137.44%).GTHX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX TTM FCF
-$37.54 M
-$19.36 M-106.47%
30 June 2024
Summary:
As of February 1, 2025, GTHX TTM free cash flow is -$37.54 million, with the most recent change of -$19.36 million (-106.47%) on June 30, 2024. Over the past year, it has increased by +$29.31 million (+43.84%).GTHX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.3% | -137.4% | +43.8% |
| 3 y3 years | +54.2% | -137.4% | +43.8% |
| 5 y5 years | +48.9% | +77.1% | +66.9% |
GTHX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +175.2% | -137.4% | +602.1% |
G1 Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$5.27 M(-40.7%) | -$37.54 M(+106.5%) |
| Mar 2024 | - | -$8.90 M(-30.4%) | -$18.18 M(-52.6%) |
| Dec 2023 | -$38.34 M(-70.3%) | -$12.79 M(+20.9%) | -$38.34 M(-31.8%) |
| Sept 2023 | - | -$10.58 M(-175.1%) | -$56.18 M(-16.0%) |
| June 2023 | - | $14.09 M(-148.5%) | -$66.85 M(-44.3%) |
| Mar 2023 | - | -$29.05 M(-5.2%) | -$120.00 M(-7.1%) |
| Dec 2022 | -$129.13 M(-2.3%) | -$30.63 M(+44.2%) | -$129.13 M(-3.0%) |
| Sept 2022 | - | -$21.25 M(-45.6%) | -$133.15 M(-8.8%) |
| June 2022 | - | -$39.06 M(+2.3%) | -$145.99 M(+1.8%) |
| Mar 2022 | - | -$38.18 M(+10.2%) | -$143.41 M(+8.6%) |
| Dec 2021 | -$132.11 M(+57.8%) | -$34.66 M(+1.7%) | -$132.11 M(+2.4%) |
| Sept 2021 | - | -$34.08 M(-6.6%) | -$128.96 M(+41.3%) |
| June 2021 | - | -$36.49 M(+35.7%) | -$91.24 M(+9.1%) |
| Mar 2021 | - | -$26.88 M(-14.7%) | -$83.60 M(-0.2%) |
| Dec 2020 | -$83.74 M | -$31.51 M(-965.8%) | -$83.74 M(+0.5%) |
| Sept 2020 | - | $3.64 M(-112.6%) | -$83.34 M(-26.5%) |
| June 2020 | - | -$28.85 M(+6.7%) | -$113.33 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$27.02 M(-13.1%) | -$107.55 M(+5.1%) |
| Dec 2019 | -$102.29 M(+36.4%) | -$31.11 M(+18.1%) | -$102.29 M(+10.6%) |
| Sept 2019 | - | -$26.35 M(+14.2%) | -$92.52 M(+10.9%) |
| June 2019 | - | -$23.06 M(+6.0%) | -$83.39 M(+6.1%) |
| Mar 2019 | - | -$21.76 M(+2.0%) | -$78.60 M(+4.8%) |
| Dec 2018 | -$75.02 M(+47.6%) | -$21.34 M(+23.9%) | -$75.02 M(+9.6%) |
| Sept 2018 | - | -$17.22 M(-5.7%) | -$68.45 M(+5.0%) |
| June 2018 | - | -$18.27 M(+0.5%) | -$65.22 M(+9.2%) |
| Mar 2018 | - | -$18.18 M(+23.1%) | -$59.70 M(+17.5%) |
| Dec 2017 | -$50.81 M(+100.1%) | -$14.77 M(+5.6%) | -$50.81 M(+12.2%) |
| Sept 2017 | - | -$13.99 M(+9.7%) | -$45.29 M(+23.4%) |
| June 2017 | - | -$12.76 M(+37.3%) | -$36.71 M(+25.1%) |
| Mar 2017 | - | -$9.29 M(+0.5%) | -$29.34 M(+15.5%) |
| Dec 2016 | -$25.39 M(+82.2%) | -$9.25 M(+71.0%) | -$25.39 M(+57.3%) |
| Sept 2016 | - | -$5.41 M(+0.5%) | -$16.14 M(+50.4%) |
| June 2016 | - | -$5.38 M(+0.7%) | -$10.73 M(+100.7%) |
| Mar 2016 | - | -$5.35 M | -$5.35 M |
| Dec 2015 | -$13.93 M | - | - |
FAQ
- What is G1 Therapeutics annual free cash flow?
- What is the all time high annual FCF for G1 Therapeutics?
- What is G1 Therapeutics annual FCF year-on-year change?
- What is G1 Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for G1 Therapeutics?
- What is G1 Therapeutics quarterly FCF year-on-year change?
- What is G1 Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for G1 Therapeutics?
- What is G1 Therapeutics TTM FCF year-on-year change?
What is G1 Therapeutics annual free cash flow?
The current annual FCF of GTHX is -$38.34 M
What is the all time high annual FCF for G1 Therapeutics?
G1 Therapeutics all-time high annual free cash flow is -$13.93 M
What is G1 Therapeutics annual FCF year-on-year change?
Over the past year, GTHX annual free cash flow has changed by +$90.79 M (+70.31%)
What is G1 Therapeutics quarterly free cash flow?
The current quarterly FCF of GTHX is -$5.27 M
What is the all time high quarterly FCF for G1 Therapeutics?
G1 Therapeutics all-time high quarterly free cash flow is $14.09 M
What is G1 Therapeutics quarterly FCF year-on-year change?
Over the past year, GTHX quarterly free cash flow has changed by -$19.36 M (-137.44%)
What is G1 Therapeutics TTM free cash flow?
The current TTM FCF of GTHX is -$37.54 M
What is the all time high TTM FCF for G1 Therapeutics?
G1 Therapeutics all-time high TTM free cash flow is -$5.35 M
What is G1 Therapeutics TTM FCF year-on-year change?
Over the past year, GTHX TTM free cash flow has changed by +$29.31 M (+43.84%)